Home›Companies›Biotech & Pharma›Azora Therapeutics

Azora Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 9, 2023·Suggest an edit

About Azora Therapeutics

Azora Therapeutics is a private company based in Encino, California. It has reported $8,316,351 raised in two offerings on Form D since June 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 2, 2023Aug 9, 2023$581,449of $596K target11$52,859EquityRule 506(b)Form D ↗
Jun 1, 2021Jun 14, 2021$7,734,902of $8.3M target108$71,619EquityRule 506(b)Form D ↗
Total, two offerings$8,316,351

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Azora Therapeutics's Form D filed Aug 9, 2023.

DB
Dennis Brown
Director
JS
Julie Saiki
Secretary and director
MD
Matthew Davidson
Executive officer and director

Sources

  1. SECAzora Therapeutics, Inc. filing history